oramorph 20mg/ml oralne kapi, rastvor
druŠtvo sa ograniČenom odgovornoŠĆu "inpharm co" podgorica - morfin - oralne kapi, rastvor - 20mg/ml
tantum verde 0.15% rastvor za ispiranje usta
"farmont m.p." d.o.o. za proizvodnju, promet i usluge, export-import danilovgrad - benzidamin - rastvor za ispiranje usta - 0.15%
tantum verde 0.15% rastvor za ispiranje usta
"farmont m.p." d.o.o. za proizvodnju, promet i usluge, export-import danilovgrad - benzidamin - rastvor za ispiranje usta - 0.15%
aerius
n.v. organon - dcsloratadin - rhinitis, allergic, perennial; urticaria; rhinitis, allergic, seasonal - antihistaminici za sistemsku primjenu, - Эриус je propisan za ublažavanje simptoma povezanih s:alergijski rinitis;osip.
aldara
viatris healthcare limited - imikimod - condylomata acuminata; keratosis; keratosis, actinic; carcinoma, basal cell - antibiotici i kemoterapeutici za dermatološku uporabu - imiquimod cream is indicated for the topical treatment of :external genital and perianal warts (condylomata acuminata) in adults. small superficial basal cell carcinomas (sbccs) in adults. clinically typical, nonhyperkeratotic, nonhypertrophic actinic keratoses (aks) on the face or scalp in immunocompetent adult patients when size or number of lesions limit the efficacy and/or acceptability of cryotherapy and other topical treatment options are contraindicated or less appropriate.
ameluz
biofrontera bioscience gmbh - 5-aminolevulinska kiselina hidroklorid - keratosis, actinic; carcinoma, basal cell - antineoplastična sredstva - liječenje актинического кератоза blage i umjerene težine na licu i vlasištu (olsen klasa 1 i 2; vidi odjeljak 5. 1) i polje cancerization kod odraslih. tretman površina i/ili узелковый karcinom bazalnih stanica neprikladne za kirurško liječenje zbog mogućeg liječenja bolesti i/ili nezadovoljavajuće kozmetički rezultat kod odraslih.
arava
sanofi-aventis deutschland gmbh - leflunomid - arthritis, rheumatoid; arthritis, psoriatic - imunosupresivi - leflunomide indiciran za liječenje odraslih bolesnika s:aktivni reumatoidni artritis kao bolest-mijenjanje противоревматические lijekovi (dmards);aktivni psorijatični artritis. najnovije ili istodobno liječenje гепатотоксичными ili haematotoxic lijekovima (e. metotreksat) može dovesti do povećanog rizika od ozbiljnih nuspojava; stoga treba započeti liječenje leflunomidom pažljivo u vezi s tim aspektima koristi / rizika. osim toga, prebacivanje s лефлуномидом u drugi dmards bez vođenja postupka ispiranja također može povećati rizik od ozbiljnih nuspojava, čak i za dugo nakon komutacije.
aubagio
sanofi winthrop industrie - teriflunomide - multipla skleroza - selektivni imunosupresivi - aubagio is indicated for the treatment of adult patients and paediatric patients aged 10 years and older with relapsing remitting multiple sclerosis (ms) (please refer to section 5. 1 for important information on the population for which efficacy has been established).
azomyr
n.v. organon - dcsloratadin - rhinitis, allergic, perennial; urticaria; rhinitis, allergic, seasonal - antihistaminici za sistemsku primjenu, - azomyr is indicated for the relief of symptoms associated with:allergic rhinitis (see section 5. 1)urticaria (see section 5.
faslodex
astrazeneca ab - fulvestrant od - neoplazme dojki - endokrini terapija, anti-estrogeni - faslodex is indicated , as monotherapy for the treatment of estrogen receptor positive, locally advanced or metastatic breast cancer in postmenopausal women:, , not previously treated with endocrine therapy, or, with disease relapse on or after adjuvant antiestrogen therapy, or disease progression on antiestrogen therapy. , , , in combination with palbociclib for the treatment of hormone receptor (hr)-positive, human epidermal growth factor receptor 2 (her2)-negative locally advanced or metastatic breast cancer in women who have received prior endocrine therapy. u pre - ili perimenopauzi, u sveobuhvatnoj liječenju s palbociclib treba kombinirati s luteinizirajućeg hormona releasing hormon (lhrh) agonist.